Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Basal Cell 1

Interventions

HhAntag691 14sonidegib 4methyl 5-aminolevulinate 3Photochemotherapy 3Aminolevulinic Acid 3tazarotene 2cemiplimab 2IPI-926 2Drug Evaluation 21-phenyl-3,3-dimethyltriazene 2silmitasertib 1remetinostat 1prednylidene 1pembrolizumab 1deltacortene 1Tacrolimus 1Risk Factors 1Prednisone 1Nivolumab 1NVP-BKM120 1Mohs Surgery 1Mindfulness 1Midazolam 1Itraconazole 1Ipilimumab 1IFL protocol 1Folfox protocol 1Fluorouracil 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Basal Cell × silmitasertib × Clear all
NCT03897036 2025-05-20

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Senhwa Biosciences, Inc.

Phase 1 Completed
25 enrolled 9 charts
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡